SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-032972
Filing Date
2020-12-08
Accepted
2020-12-08 09:21:05
Documents
1
Period of Report
2020-12-02

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6105
  Complete submission text file 0000899243-20-032972.txt   7918
Mailing Address 2 RIGHTER PARKWAY, SUITE 200 WILMINGTON DE 19803
Business Address 35 WILBUR ST LYNBROOK NY 11563 302-842-8450
BIOSPECIFICS TECHNOLOGIES CORP (Issuer) CIK: 0000875622 (see all company filings)

IRS No.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000
Business Address MINERVA HOUSE, SIMMONSCOURT ROAD BALLSBRIDGE DUBLIN 4 L2 00000 353-1-268-2000
Endo International plc (Reporting) CIK: 0001593034 (see all company filings)

Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-34236 | Film No.: 201374515
SIC: 2834 Pharmaceutical Preparations